Targeting mTOR in HIV-Negative Classic Kaposi's Sarcoma
Joint Authors
Merimsky, Ofer
Sagi-Eisenberg, Ronit
Jiveliouk, Irina
Source
Issue
Vol. 2008, Issue 2008 (31 Dec. 2008), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2008-05-15
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
A 66-year old female with HIV-negative classic Kaposi's sarcoma responded to mTOR targeting by rapamycin.
The response was well documented by PET-CT.
This case provides supporting evidence that the mTOR pathway may be important in the tumorigenesis of KS and that rapamycin may have activity in this disease.
American Psychological Association (APA)
Merimsky, Ofer& Jiveliouk, Irina& Sagi-Eisenberg, Ronit. 2008. Targeting mTOR in HIV-Negative Classic Kaposi's Sarcoma. Sarcoma،Vol. 2008, no. 2008, pp.1-4.
https://search.emarefa.net/detail/BIM-501116
Modern Language Association (MLA)
Merimsky, Ofer…[et al.]. Targeting mTOR in HIV-Negative Classic Kaposi's Sarcoma. Sarcoma No. 2008 (2008), pp.1-4.
https://search.emarefa.net/detail/BIM-501116
American Medical Association (AMA)
Merimsky, Ofer& Jiveliouk, Irina& Sagi-Eisenberg, Ronit. Targeting mTOR in HIV-Negative Classic Kaposi's Sarcoma. Sarcoma. 2008. Vol. 2008, no. 2008, pp.1-4.
https://search.emarefa.net/detail/BIM-501116
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-501116
